312
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Predictive Effect of Triglyceride-Glucose Index on Adverse Prognostic Events in Patients with Type 2 Diabetes Mellitus and Ischemic Cardiomyopathy

ORCID Icon, , , , &
Pages 1093-1107 | Received 15 Feb 2023, Accepted 06 Apr 2023, Published online: 20 Apr 2023

References

  • Ardeshna DR, Bob-Manuel T, Nanda A, et al. Asian-Indians: a review of coronary artery disease in this understudied cohort in the United States. Ann Transl Med. 2018;6(1):12. doi:10.21037/atm.2017.10.18
  • Zhang Y, Zhang J, Butler J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China-HF) Registry. J Card Fail. 2017;23(12):868–875. doi:10.1016/j.cardfail.2017.09.014
  • Shipulin VM, Pryakhin AS, Andreev SL, Shipulin VV, Kozlov BN. Results of reconstructive interventions in patients with ischemic cardiomyopathy. Asian Cardiovasc Thorac Ann. 2021;29(6):508–517. doi:10.1177/0218492320983464
  • Gheorghiade M, Sopko G, De Luca L, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114(11):1202–1213. doi:10.1161/CIRCULATIONAHA.106.623199
  • Felker GM, Shaw LK, O’Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39(2):210–218. doi:10.1016/S0735-1097(01)01738-7
  • Zhang S, Jin R, Li B. Serum NT-proBNP and TUG1 as novel biomarkers for elderly hypertensive patients with heart failure with preserved ejection fraction. Exp Ther Med. 2021;21(5):446. doi:10.3892/etm.2021.9874
  • Metra M, Carubelli V, Ravera A, Stewart Coats AJ. Heart failure 2016: still more questions than answers. Int J Cardiol. 2017;227:766–777. doi:10.1016/j.ijcard.2016.10.060
  • Filippatos G, Khan SS, Ambrosy AP, et al. International Registry to assess medical practice with longitudinal Observation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. Eur J Heart Fail. 2015;17(5):527–533. doi:10.1002/ejhf.262
  • De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol. 2018;9:2. doi:10.3389/fendo.2018.00002
  • Ray KK, Colhoun HM, Szarek M, et al. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7(8):618–628. doi:10.1016/S2213-8587(19)30158-5
  • Hueb T, Rocha MS, Siqueira SF, et al. Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial. Diabetol Metab Syndr. 2018;10:19. doi:10.1186/s13098-018-0320-y
  • van Ark J, Hammes HP, van Dijk MC, et al. Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy. Cardiovasc Diabetol. 2013;12:116. doi:10.1186/1475-2840-12-116
  • Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21(1):74. doi:10.1186/s12933-022-01516-6
  • Adeva-Andany MM, Martínez-Rodríguez J, González-Lucán M, Fernández-Fernández C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab Syndr. 2019;13(2):1449–1455. doi:10.1016/j.dsx.2019.02.023
  • Tenenbaum A, Adler Y, Boyko V, et al. Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease. Am Heart J. 2007;153(4):559–565. doi:10.1016/j.ahj.2007.01.008
  • Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM, Hernandez AV. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One. 2012;7(12):e52036. doi:10.1371/journal.pone.0052036
  • American Diabetes Association. Consensus development conference on insulin resistance. 5–6 November 1997. Diabetes Care. 1998;21(2):310–314. doi:10.2337/diacare.21.2.310
  • Wang L, Cong HL, Zhang JX, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80. doi:10.1186/s12933-020-01054-z
  • Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–197. doi:10.1111/eci.12583
  • Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18(1):361. doi:10.1186/s12916-020-01824-2
  • Zhao Q, Zhang TY, Cheng YJ, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108. doi:10.1186/s12933-020-01086-5
  • Zhang Y, Ding X, Hua B, et al. Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China. Cardiovasc Diabetol. 2021;20(1):43. doi:10.1186/s12933-021-01236-3
  • Tarantino G, Crocetto F, Di Vito C, et al. Association of NAFLD and insulin resistance with non metastatic bladder cancer patients: a cross-sectional retrospective study. J Clin Med. 2021;10(2):346. doi:10.3390/jcm10020346
  • Ng AC, Sindone AP, Wong HS, Freedman SB. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy. Int J Cardiol. 2008;129(2):198–204. doi:10.1016/j.ijcard.2007.07.014
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  • Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi:10.1186/s12933-018-0762-4
  • Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351. doi:10.1210/jc.2010-0288
  • Vasques AC, Novaes FS, de Oliveira Mda S, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100. doi:10.1016/j.diabres.2011.05.030
  • Irace C, Carallo C, Scavelli FB, et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67(7):665–672. doi:10.1111/ijcp.12124
  • Wu Z, Liu L, Wang W, et al. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):142. doi:10.1186/s12933-022-01576-8
  • Sorrentino MJ. The evolution from hypertension to heart failure. Heart Fail Clin. 2019;15(4):447–453. doi:10.1016/j.hfc.2019.06.005
  • Li J, Yu S, Zhou W, et al. U-shaped association of body mass index with the risk of peripheral arterial disease in Chinese hypertensive population. Int J Gen Med. 2021;14:3627–3634. doi:10.2147/IJGM.S323769
  • Zhu L, Wu G, Yang X, et al. Low density lipoprotein mimics insulin action on autophagy and glucose uptake in endothelial cells. Sci Rep. 2019;9(1):3020. doi:10.1038/s41598-019-39559-7